InterMune Reports Top-Line Results From Phase 2b Study of Danoprevir (RG7227/ITMN-191) in Patients with Chronic Hepatitis C http://finance.yahoo.com/news/InterMune-Reports-TopLine-prnews-1072476486.html?x=0&.v=1